Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.
Jupiter Life Line Hospitals has been operating as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the “Jupiter” brand in Thane, Pune, and Indore, with a total operational bed capacity of 1194 beds, and 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023. The company is currently developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has commenced construction in April 2023.
According to the CRISIL Report, the company’s Thane and Indore hospitals are amongst the few hospitals in the western region of India to provide neuro-rehabilitation services through a dedicated robotic and computer-assisted neuro-rehabilitation center. Additionally, it operates one of the few multi-organ transplant centers in Thane. All the hospitals in Thane, Pune, and Indore have been certified by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and have been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
The company’s inpatient and outpatient revenue is diversified across hospitals with Thane, Pune, and Indore hospitals accounting for 54.18%, 34.03%, and 11.79%, respectively, of the revenue from operations in Fiscal 2023.
Jupiter Life Line Hospitals IPO Details
Jupiter Life Line Hospitals IPO is a Book Built Issue. The IPO total issue size is Rs 869.08 Cr. The Jupiter Life Line Hospitals IPO price is ₹695 to ₹735 per share. The IPO will list on BSE, NSE.
| IPO Date | September 6, 2023 to September 8, 2023 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price | ₹695 to ₹735 per share |
| Lot Size | 20 Shares |
| Total Issue Size | 11,824,163 shares (aggregating up to ₹869.08 Cr) |
| Fresh Issue | 7,374,163 shares (aggregating up to ₹542.00 Cr) |
| Offer for Sale | 4,450,000 shares of ₹10 (aggregating up to ₹327.08 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 58,191,859 |
| Share holding post issue | 65,566,022 |
Jupiter Life Line Hospitals IPO Reservation
| QIB Shares Offered | Not more than 50.00% of the Net offer |
| NII (HNI) Shares Offered | Not less than 15.00% of the Offer |
| Retail Shares Offered | Not less than 35.00% of the Offer |
Jupiter Life Line Hospitals IPO Timetable (Tentative)
Jupiter Life Line Hospitals IPO opens on September 6, 2023, and closes on September 8, 2023.
| IPO Open Date | Wednesday, September 6, 2023 |
| IPO Close Date | Friday, September 8, 2023 |
| Basis of Allotment | Wednesday, September 13, 2023 |
| Initiation of Refunds | Thursday, September 14, 2023 |
| Credit of Shares to Demat | Friday, September 15, 2023 |
| Listing Date | Monday, September 18, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on September 8, 2023 |
Jupiter Life Line Hospitals IPO Lot Size
The minimum lot size of this Jupiter Life Line Hospitals IPO is 20 shares required is ₹14,700.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 20 | ₹14,700 |
| Retail (Max) | 13 | 260 | ₹191,100 |
| S-HNI (Min) | 14 | 280 | ₹205,800 |
| S-HNI (Max) | 68 | 1,360 | ₹999,600 |
| B-HNI (Min) | 69 | 1,380 | ₹1,014,300 |
| Lot Size Calculator |
Jupiter Life Line Hospitals IPO Promoter Holding
Dr. Ajay Thakker, Dr. Ankit Thakker, and Western Medical Solutions LLP are the promoters of the company.
| Pre Issue Share Holding | 40.69% |
| Post Issue Share Holding |
Company Financials
| Period Ended | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
| Assets | 788.91 | 908.70 | 985.53 |
| Revenue | 490.27 | 737.14 | 902.96 |
| Profit After Tax | -2.30 | 51.13 | 72.91 |
| Net Worth | 246.44 | 288.43 | 363.91 |
| Reserves and Surplus | |||
| Total Borrowing | 425.52 | 495.25 | 468.63 |
Amount in ₹ Crore
Key Performance Indicator
Jupiter Life Line Hospitals IPO Market Cap is Rs 4819.1 Cr and P/E (x) is 52.68.
| KPI | Values |
|---|---|
| P/E (x) | 52.68 |
| Market Cap (₹ Cr.) | 4819.1 |
| ROE | 20.03% |
| ROCE | 20.94% |
| EPS (Rs) | 13.95 |
| RoNW | 20.03% |
Check Jupiter Life Line Hospitals IPO Peer Comparison here.
Objects of the Issue
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
- Repayment/pre-payment, in full or part, of borrowings availed from banks by the company and Material Subsidiary; and
- General corporate purposes.
Jupiter Life Line Hospitals IPO Review (Apply)
[Dilip Davda] JLLHL is a known chain of Hospitals in the MMR regions and gaining preference due to its high-tech and advanced healthcare services with ultramodern diagnostic services. Based on FY23 earnings, the issue appears fully priced. Post Covid, preference for better-equipped healthcare centres is on the rise and this company is rightly placed in that category. The company also has plans to expand its footprint in the Western Regions. Considering the fancy for the branded chain of hospitals, investors may consider investment for the medium to long term in this issue. Read detail review…
Jupiter Life Line Hospitals IPO Prospectus
Company Contact Information
Jupiter Life Line Hospitals Limited
1004, 10th Floor, 360 Degree Business Park,
Maharana Pratap Chowk, LBS Marg,
Mulund (West), Mumbai – 400 080
Phone: + 91 22 2172 5623
Email: cs@jupiterhospital.com
Website: https://www.jupiterhospital.com/
Jupiter Life Line Hospitals IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: jupiterlife.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/